1. Secondary metabolites of Curvularia sp. G6-32, an endophyte of Sapindus saponaria, with antioxidant and anticholinesterasic properties
- Author
-
Maria Helena Sarragiotto, Márcia Regina Pereira Cabral, Andressa Domingos Polli, João Lúcio de Azevedo, Angela Aparecida da Silva, Adriana Garcia, Ravely Casarotti Orlandelli, Juliana Cristina Castro, Benício Alves de Abreu-Filho, Marcos A. Ribeiro, Julio Cesar Polonio, Caroline Menicoze dos Santos, and João Alencar Pamphile
- Subjects
Sapindus saponaria ,Antioxidant ,Traditional medicine ,biology ,Chemistry ,medicine.medical_treatment ,Organic Chemistry ,Biological activity ,Plant Science ,biology.organism_classification ,Sapindus ,Biochemistry ,Endophyte ,Analytical Chemistry ,Curvularia sp ,Asperpentyn ,medicine - Abstract
In the present study, the biological activity of an extract of the secondary metabolites (E-G6-32) produced by the Curvularia sp. G6-32 endophyte (isolated from the medicinal plant Sapindus saponaria L.) was investigated. The antioxidant potential was confirmed by the DPPH (22.5%) and ABTS (62.7%) assays, and the total phenolic compound content was 40 µg gallic acid equivalents/mg. The extract E-G6-32 displayed good inhibitory activity toward butyrylcholinesterase (BuChE; IC50 = 110 ± 0.05 µg mL−1). The extract E-G6-32 was subjected to spectroscopic and mass spectrometry analyses. Comparison with the literature data confirmed that (-)-asperpentyn (1) was a major component. Asperpentyn belongs to the epoxyquinone family, which has attractive structural complexity, diverse functional groups, and a broad range of biological activities, including specific enzyme inhibitory activity. Our results suggest that Curvularia sp. G6-32 is a promising source of bioactive secondary metabolites and contains (-)-asperpentyn, which has potential pharmaceutical interest.
- Published
- 2022
- Full Text
- View/download PDF